by
Dr Khurrum Shaukat Yusafzai ,
Hyperbaric Medical Consultant.
CLICK TO SEE VIDEO : https://youtu.be/4Icotcl7Uos
- As World Faces Severe Shortage of Ventilators ,
- Hyperbaric Chambers are possible Replacement of Ventilators
- Proving to be Far Better than the Ventilators in many ways, in treatment of Covid-19.
- Increase of Healing the Covid-19
- Reduction in Inflammation
- Reduction in Lymphocytes , Fibronogin , CRP and D-Dimers
- Replication of Chinese Study of Similar Nature
Today I show you Covid-19 treatment via Hyperbaric Medicine in Spain and race by other Countries to adopt it.
So let's begin and See my Video on You tube channel that you have to Subscribe and Press the Bell Icon for Informative Videos :
SPAIN :
In Madrid Spain, in epicenter of Corona Virus . in HLA Moncloa Hospital
Progressive Hypoxia of the Patients know as SARS , Severe Acute Respiratory Syndrome was treated by Hyperbaric Chambers .
Patients were not getting Better even with Mechanical Assisted Respiration with the Ventilators ,
SARS was endangering their lives that could lead to Certain death ,
RESEARCH :
Hyperbaric Chambers Provided by Oxybarica Spain are being utilised as an Alternative to Ventilators in Treatment of many Diseases including SARS , Severe Acute Respiratory Distress Syndrome .
Hyperbaric Chambers as Oxygenation Devices that are Classified as Class 2 Devices just like Ventilators , but far More Power full .
Link to Research Article:
The results were Published online: 2020-04-24 ,
Research Led by:
Dr. José Fabregat Sancho.
Specialist in Neurosurgery
Specialist in Subaquatic and hyperbaric medicine
Universitary chair director. Hyperbaric Oxygen Therapy. UCAM University.
OHB Foundation
METHODE
SARS from Covid-19 , Critical Patient Progressive Hypoxia that was un-corrected with Ventilators and ECMO , due to Inflammation of Lungs and Severed Secretions .
HBOT Cleared of SARS Corona Virus , In Matter of just 4-5 sessions, each consisting of 60 Minute at 2 ATA Pressure was used.
Hyperbaric Chamber Proved to be very Powerful Therapy to remove Progressive Hypoxia caused by SARS .
The Hyperbaric Therapy proved to be Decider between life and death , Providing a solution to Failure of Organs.
The Patients responded to Treatment in the , First Session even ,
HBOT proved that even 2 session were enough to save the Lives of Patients having SARS .
The Research Paper, demonstrated that critical Patients after taking 5 session are devoid of symptoms of Fever , cough and Breathlessness
CT Scans of Chest and lungs proved the Point and Partial Pressure of Oxygen also Increased.
Proper , Disinfection methods was carried out to save the staff and people from the , getting cross Infections.
Higher CRP Levels which have become Reliable Indicator of SARS caused by Virus infection due to Covid-19 , due to Progressive Hypoxia was shown to be reduced Significantly after the HBOT .
The Low counts of Lymphocytes found to be an Indication of Higher Mortality also Improved to Higher counts .
The lactic Acid in the Body another Indicator of Hypoxia due to SARS and Virus Infection due to Covid-19 , was also shown to Decrease.
Even Having Normal Pulmonary Function after Covid-19 , Imbalance between the Oxygen Demand and supply lead to SARS Hypoxia . Leading to Inflammations of Lungs Due to SARS .
The HBOT Corrects this Dilemma, it is about Time the WHO , World health Organisation should Include this as one of recommended treatment for SARS Covid-19 Disease
Patients with COVID-19 present a pneumonia with severe lung involvement, large inflammatory component and structural damage at different levels, such as hemoglobin . This global hypoxia caused multi organ damage. The WHO said that "oxygen is the major treatment intervention for patients with covid-19. The most powerful oxygen therapy with the greatest capacity to supply oxygen that we knew was the hyperbaric chamber since it allows a non-invasive contribution of O2 to 100% and also added the biological effects of increased pressure. Here we show the outcome of COVID-19 patients treated with HBOT
Method
Seven patients diagnosed with COVID-19. The initial objective was to treat clinically compromised patients, with a poor response to the base treatment and risk of worsening, needing ICU admission and connection to a ventilator. We could see the evolution of the analytical parameters: lymphocytes, ferritin, fibrinogen, D-dimer and CRP. We analyzed the oxygen saturation and the need for external oxygen supply.
Findings
All the patients tolerated the treatment very well. They were feeling better, the general message was of subjective improvement. The general trend was an improvement in O2 saturation accompanied by a reduction in the need for external oxygen supply. Tendency of the majority of patients to stabilize / improve the analytical data respect to the status of admission and / or start of treatment. The resuls suggested HBOT could improve/stabilize clinical evolution in COVID-19 patiens even help them to recover
Understandably we are aware that this is a short and heterogeneous sample that does not allow us to draw definitive conclusions and, of course, it is not our intention to issue dogmas in this regard.
However, what has been seen in these patients and what other authors tell us suggests that treatment with hyperbaric oxygen therapy can promote aerobic metabolism, correct hypoxia, improve perfusion and oxygen supply to tissues, reduce the component inflammatory etc.
It does not consist of converting the HBOT into a single treatment, nor of replacing the medical treatments that are being administered and studied, but rather about incorporating this therapeutic possibility into the usual treatments of these patients.
Given the limited experience and clinical instability of the patients, we believe that these treatments should be performed in a hospital environment and always with equipment that meets the basic requirements of providing 100% O2 and high pressure, since is pressure and not another variable which makes the availability of free O2 in plasma multiply by much.
Although the situation has improved compared to previous weeks, we are still fully immersed in the pandemic and we do not know the evolution this may have over time. We appeal to our colleagues who have these equipments to treat patients with COVID-19 and to the health authorities to provide this type of equipment to health institutions to continue treating patients, who are still many, and to be prepared for the possible needs that may arise in the future.
SUMMARY
BackgroundPatients with COVID-19 present a pneumonia with severe lung involvement, large inflammatory component and structural damage at different levels, such as hemoglobin . This global hypoxia caused multi organ damage. The WHO said that "oxygen is the major treatment intervention for patients with covid-19. The most powerful oxygen therapy with the greatest capacity to supply oxygen that we knew was the hyperbaric chamber since it allows a non-invasive contribution of O2 to 100% and also added the biological effects of increased pressure. Here we show the outcome of COVID-19 patients treated with HBOT
Method
Seven patients diagnosed with COVID-19. The initial objective was to treat clinically compromised patients, with a poor response to the base treatment and risk of worsening, needing ICU admission and connection to a ventilator. We could see the evolution of the analytical parameters: lymphocytes, ferritin, fibrinogen, D-dimer and CRP. We analyzed the oxygen saturation and the need for external oxygen supply.
Findings
All the patients tolerated the treatment very well. They were feeling better, the general message was of subjective improvement. The general trend was an improvement in O2 saturation accompanied by a reduction in the need for external oxygen supply. Tendency of the majority of patients to stabilize / improve the analytical data respect to the status of admission and / or start of treatment. The resuls suggested HBOT could improve/stabilize clinical evolution in COVID-19 patiens even help them to recover
CONCLUSION
Understandably we are aware that this is a short and heterogeneous sample that does not allow us to draw definitive conclusions and, of course, it is not our intention to issue dogmas in this regard.
However, what has been seen in these patients and what other authors tell us suggests that treatment with hyperbaric oxygen therapy can promote aerobic metabolism, correct hypoxia, improve perfusion and oxygen supply to tissues, reduce the component inflammatory etc.
It does not consist of converting the HBOT into a single treatment, nor of replacing the medical treatments that are being administered and studied, but rather about incorporating this therapeutic possibility into the usual treatments of these patients.
Given the limited experience and clinical instability of the patients, we believe that these treatments should be performed in a hospital environment and always with equipment that meets the basic requirements of providing 100% O2 and high pressure, since is pressure and not another variable which makes the availability of free O2 in plasma multiply by much.
Although the situation has improved compared to previous weeks, we are still fully immersed in the pandemic and we do not know the evolution this may have over time. We appeal to our colleagues who have these equipments to treat patients with COVID-19 and to the health authorities to provide this type of equipment to health institutions to continue treating patients, who are still many, and to be prepared for the possible needs that may arise in the future.
KSYBIZ HYPERBARIC CHANNEL
Please Subscribe to my " KSYBIZ " Hyperbaric Channel to highly Informative Videos and to encourage our Hard Work .
And For Any Question You can contact me below on the Social Media Apps shown on the floating Bar at the bottom.
Bye and take care and see you soon,
Thanking you in Anticipation,
From,
Dr. Khurrum Shaukat Yousafzai
Director Chinar Trust Hospital,
Director Ksy Hyperbarics Consultancy,
Founder Hyperbaric Medical Society Pakistan,
Twitter: ksybiz
We Chat :ksybiz
LinkedIn: ksybiz
YouTube: ksybiz
Skype: Dr Khurrum Shaukat
Web: ksybiz.wixsite.com/hbot
Blogsite: ksybiz.blogspot.com
Facebook: facebook.com/hbotpk
Mobile / Whatsapp: +92 343 2 333 555
No comments:
Post a Comment